Member Info for Gobbygnome

Agree the day of carrots is long gone. That may be advantageous on next releases, or not

Could do. 1000s% v 50/60% punt seems fair on news though. Given there has been none for so long . There won't be a spike. They had no interest in selling own stock so no need for them example Avant

Find out by week 3 close for sure

Yes later. Hard to know to the exact hour . Looking at close I suspect big news tomorrow. Week 3 of the month will get huge. Hopefully not have to wait until momday morning for the JPM style appearance

Anyway, I can see at least 80 deals and 160 questions. I'm sure every ture compliment for moi, will encourage future dissection 1x1

Your friend

Gobby

Alone.. lol

In no way was I suggesting fraud. Just a possible typo error that may have not wholly misled market

Indeed, a fair few other RNSs in no way insinuate the same

In fact, I may even invest just in the credibility factor along

"Velinoff will have a dedicated team including a brand manager and three medical sales representatives along with an existing team of sales representatives promoting product sales"

Massive sales team. Maybe they should try sell a sachet instead of a whole box?

12 Mar 2020 07:00

RNS Number : 8261F

OptiBiotix Health PLC

12 March 2020

OptiBiotix Health plc

("OptiBiotix" or the "Company")

New partner for LPLDL® in Bulgaria

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, cardiovascular disease and diabetes, announces that its wholly-owned subsidiary ProBiotix Health Ltd. ("ProBiotix"), has signed a licencing agreement with Velinoff Pharma Ltd ("Velinoff") for the distribution of ProBiotix's product CholBiome® and CholBiome®X3, which contains OptiBiotix's patented probiotic strain LPLDL®, in Bulgaria.

Under the terms of the agreement, Velinoff will promote the sale of CholBiome® and CholBiome®X3 containing LPLDL® under a non-exclusive licence to pharmacies, cardiologists, general practitioners, and cardiologic clinics in Bulgaria. Velinoff will have a dedicated team including a brand manager and three medical sales representatives along with an existing team of sales representatives promoting product sales. The agreement is based on minimum sales volumes.

This agreement replaces the agreement announced previously (RNS: 26 September 2018) with an unnamed distributor and eliminates an intermediary in the supply chain with a shorter route to market allowing closer partner working.

.....

Anyone w er find out who the other distributer was prior? With thousands of sales channels?

Interesting, Velinoff was set up around the same time as the pbx CLN at opti. Also, velonoff were advertising opti products in Facebook from tbe same time , despite the exclusivity for the NDA distrubutor at also the same time

Just wondering were qires crossed and it was always Velinoff ? After all as seen at PBX, typo errors can happen

Even I am not immune to them

Later should see a pop up . Every reason for it even pre news really. It would take extensive MM work to stop it

PBX needed cash. And O Hara isn't shy of designing raises in both parent and spin outs...

Excuse mistypes.

PBX needed cash. And O Hara isn't shut of designing raises in bkth larent and spin outs

I think the anger with the PBX raise, is simply no cut later

First time in a decade , a raise angers him on behalf of retail supposedly lol. Be ause he couldn't work the angle for himself

It's like sverythung is designed for 1. A full take and 2. A cut later

Awful

Cont.

Anyone ever notice that anything to do with actual cash, always , without exception , was designed to suit anyone but retail ? I literally cant find one in cash terms, that didn't devalue us to enrich others

And pretty blatant too.

With around a decade of RNS's to peruse (entertaining to say the least

I think we need to name the week coming

"The Jacob Gate"

Rocketship dudes. Time to stop talking

Gobby

The Jacob Programme has ended. Now yiu get news . The 7 markets days including today, will be gargantuan

I'm surprised none of tou noticed the Jacob slip anyway. You need to read data elsewhere

If you ask me, retail investors got a 50% discount re O Hara not handling it.

I assume the family were not mates though tbf, or the unamed partners

I just don't understand the issue with the £1M raise at pbx. It was a straight forward raise. Look at the cost and peronal gains if Steen didn't handle it, for circa the same money raised. Re CLN 2018

OptiBiotix plc has subscribed for £250,000 of CLNs. Steve O'Hara, a director of the Company, has subscribed for £25,000 and certain close family members of Mr. O'Hara have subscribed for £265,000. In addition, Per Rehné, a director of the Company, has subscribed for £25,000. The remaining subscribers include two institutional investors and two industry partners.

The CLNs can be converted at a fifty per cent. discount to the issue price of ProBiotix shares in the event of an IPO. The CLNs carry an interest rate of 3% per annum above the Bank of England Base Rate.

As of 14 December 2018, Steve O'Hara has an interest in 10,103,029 ordinary shares in the Company, representing 11.9 per cent. of the Company's issued share capital and has an interest in a further 6,099,135 ordinary shares under option.

There seems rmto be a lot of anger here. I am obviously a novice investor as are all, given it is illegal to be on forums otherwise

I think guru's are on forums too but don't worry. Never classed as professional people either.

So, a bit of understanding and respect for each other would be far better . And we can all invest wisely in SYME